New Irish Generics Body Wants “Fundamental” Reform Of Medicines Procurement
Executive Summary
Two generic industry associations have merged to form a single body that includes the largest generic companies in Ireland. Medicines For Ireland has marked its creation by saying it plans to push for a reform of Irish medicines procurement policies, particularly in areas such as tackling drug shortages, and has called for action to promote the use of biosimilars.
You may also be interested in...
Medicines For Ireland Lays Out Priorities For Boosting Access To Generics And Biosimilars
A new Irish generics medicines body has published a policy manifesto calling on the government to take action on pricing, competition, biosimilars and market access.
Medicines For Ireland Lays Out Priorities For Boosting Access To Generics And Biosimilars
A new Irish generics medicines body has published a policy manifesto calling on the government to take action on pricing, competition, biosimilars and market access.
Biosimilar Firms Say Irish Price Deal Hinders Uptake, As Govt Plans New Policy Measures
The Irish health ministry is planning measures to boost the prescribing of biosimilar medicines, but companies marketing biosimilars say that the pricing agreement signed last year by the originator industry and the government has served to hinder uptake of their products.